NYSE:CHE (USA) Also trade in: Germany

Chemed Corp

$ 345.42 -1.24 (-0.36%)
Volume: 69,215 Avg Vol (1m): 104,192
Market Cap $: 5.51 Bil Enterprise Value $: 5.60 Bil
P/E (TTM): 28.12 P/B: 9.70
Earnings Power Value 89.5
Net Current Asset Value -19.53
Tangible Book 0.58
Projected FCF 111.36
Median P/S Value 123.21
Graham Number 12.64
Peter Lynch Value 81.36
DCF (FCF Based) 189.72
DCF (Earnings Based) 205.18
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.09
Cash-To-Debt ranked lower than
69.71% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
CHE: 0.09
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.16, Max: 2.78
Current: 0.09
0
2.78
Equity-to-Asset 0.55
Equity-to-Asset ranked higher than
66.54% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
CHE: 0.55
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.31, Med: 0.51, Max: 0.61
Current: 0.55
0.31
0.61
Debt-to-Equity 0.17
Debt-to-Equity ranked higher than
84.16% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
CHE: 0.17
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.13, Med: 0.4, Max: 1.17
Current: 0.17
0.13
1.17
Debt-to-EBITDA 0.36
Debt-to-EBITDA ranked higher than
84.08% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
CHE: 0.36
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.32, Med: 0.82, Max: 1.09
Current: 0.36
0.32
1.09
Interest Coverage 50.17
Interest Coverage ranked higher than
68.72% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
CHE: 50.17
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 9.2, Med: 16.57, Max: 50.65
Current: 50.17
9.2
50.65
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.90
DISTRESS
GREY
SAFE
Beneish M-Score -2.70
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 33%
WACC 7.21%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 13.63
Operating Margin ranked lower than
50.37% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
CHE: 13.63
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 9.79, Med: 11.44, Max: 13.76
Current: 13.63
9.79
13.76
Net Margin % 11.37
Net Margin ranked higher than
61.03% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
CHE: 11.37
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 5.46, Med: 6.37, Max: 11.53
Current: 11.37
5.46
11.53
ROE % 36.50
ROE ranked higher than
82.35% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
CHE: 36.5
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 16.88, Med: 20.12, Max: 36.5
Current: 36.5
16.88
36.5
ROA % 21.09
ROA ranked higher than
84.25% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
CHE: 21.09
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 8.81, Med: 10.85, Max: 21.69
Current: 21.09
8.81
21.69
ROC (Joel Greenblatt) % 154.91
ROC (Joel Greenblatt) ranked higher than
86.76% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
CHE: 154.91
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 91.69, Med: 168.72, Max: 190.39
Current: 154.91
91.69
190.39
3-Year Total Revenue Growth Rate 4.90
3-Year Revenue Growth Rate ranked higher than
53.08% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
CHE: 6.2
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -19.5, Med: 8, Max: 42.9
Current: 6.2
-19.5
42.9
3-Year Total EBITDA Growth Rate 9.30
3-Year EBITDA Growth Rate ranked lower than
77.72% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
CHE: 10.6
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -29.5, Med: 10.6, Max: 72.9
Current: 10.6
-29.5
72.9
3-Year EPS w/o NRI Growth Rate 24.50
3-Year EPS w/o NRI Growth Rate ranked lower than
63.58% of 162 companies
in the Medical Care industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
CHE: 24.5
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 11.1, Max: 59.5
Current: 24.5
0
59.5

» CHE's 30-Y Financials

Financials (Next Earnings Date: 2019-07-26)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:CHE

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621610    SIC : 8082
Compare NYSE:EVHC NYSE:EHC BSP:HAPV3 LSE:NMC BKK:BH-Q NAS:LHCG NAS:AMED LSE:MDC ASX:HSO NAS:ACHC NYSE:DVA NAS:LPNT XSGO:BANMEDICA ASX:SHL JSE:LHC NSE:APOLLOHOSP NYSE:AMN NYSE:THC NYSE:MD SAU:4002
Traded in other countries CXM.Germany
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. It also manufactures products and equipment used to provide these services. Chemed generates the majority of its revenue from business in the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 28.12
PE Ratio ranked lower than
76.26% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
CHE: 28.12
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 10.72, Med: 18.8, Max: 53.3
Current: 28.12
10.72
53.3
Forward PE Ratio 27.03
Forward P/E ranked lower than
64.41% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
CHE: 27.03
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 28.12
PE without NRI ranked lower than
76.77% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
CHE: 28.12
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 10.75, Med: 18.8, Max: 53.3
Current: 28.12
10.75
53.3
Price-to-Owner-Earnings 25.83
Price-to-Owner-Earnings ranked lower than
77.98% of 109 companies
in the Medical Care industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
CHE: 25.83
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 7.86, Med: 19.6, Max: 603.86
Current: 25.83
7.86
603.86
PB Ratio 9.70
PB Ratio ranked lower than
92.49% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
CHE: 9.7
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.89, Med: 3.12, Max: 10.48
Current: 9.7
1.89
10.48
PS Ratio 3.18
PS Ratio ranked lower than
65.65% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
CHE: 3.18
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.67, Med: 1.14, Max: 3.25
Current: 3.18
0.67
3.25
Price-to-Free-Cash-Flow 23.90
Price-to-Free-Cash-Flow ranked lower than
75.56% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
CHE: 23.9
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 7.1, Med: 16.4, Max: 81.38
Current: 23.9
7.1
81.38
Price-to-Operating-Cash-Flow 19.53
Price-to-Operating-Cash-Flow ranked lower than
81.18% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
CHE: 19.53
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.92, Med: 12.46, Max: 34.86
Current: 19.53
5.92
34.86
EV-to-EBIT 23.42
EV-to-EBIT ranked lower than
79.91% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
CHE: 23.42
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 7.2, Med: 11.1, Max: 42.7
Current: 23.42
7.2
42.7
EV-to-EBITDA 20.07
EV-to-EBITDA ranked lower than
84.65% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
CHE: 20.07
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 5.9, Med: 9.1, Max: 33.7
Current: 20.07
5.9
33.7
EV-to-Revenue 3.08
EV-to-Revenue ranked lower than
58.30% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
CHE: 3.08
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.8, Med: 1.2, Max: 3.4
Current: 3.08
0.8
3.4
PEG Ratio 3.66
PEG Ratio ranked lower than
90.72% of 97 companies
in the Medical Care industry.
Industry Max: 497.4, Med: 3.13, Min: 0.11
CHE: 3.66
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.25, Med: 2.02, Max: 27.98
Current: 3.66
0.25
27.98
Shiller PE Ratio 55.55
Shiller PE Ratio ranked lower than
69.35% of 62 companies
in the Medical Care industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
CHE: 55.55
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 22.94, Med: 34.4, Max: 63.72
Current: 55.55
22.94
63.72
Current Ratio 0.73
Current Ratio ranked lower than
71.54% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
CHE: 0.73
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.5, Med: 1.21, Max: 2.32
Current: 0.73
0.5
2.32
Quick Ratio 0.70
Quick Ratio ranked lower than
68.46% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
CHE: 0.7
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.48, Med: 1.06, Max: 2.06
Current: 0.7
0.48
2.06
Days Inventory 1.68
Days Inventory ranked higher than
93.20% of 206 companies
in the Medical Care industry.
Industry Max: 464.03, Med: 17.07, Min: 0.09
CHE: 1.68
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 1.64, Med: 2.38, Max: 3.3
Current: 1.68
1.64
3.3
Days Sales Outstanding 24.17
Days Sales Outstanding ranked higher than
70.04% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
CHE: 24.17
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 16.39, Med: 24.68, Max: 32.21
Current: 24.17
16.39
32.21
Days Payable 11.64
Days Payable ranked lower than
81.25% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
CHE: 11.64
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 11.64, Med: 15.94, Max: 22.77
Current: 11.64
11.64
22.77

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.35
Trailing Dividend Yield ranked lower than
92.03% of 251 companies
in the Medical Care industry.
Industry Max: 1324.37, Med: 1.79, Min: 0.07
CHE: 0.35
Ranked among companies with meaningful Trailing Dividend Yield only.
Trailing Dividend Yield range over the past 10 years
Min: 0.33, Med: 0.72, Max: 1.2
Current: 0.35
0.33
1.2
Dividend Payout Ratio 0.10
Dividend Payout Ratio ranked higher than
92.26% of 155 companies
in the Medical Care industry.
Industry Max: 21.34, Med: 0.43, Min: 0.03
CHE: 0.1
Ranked among companies with meaningful Dividend Payout Ratio only.
Dividend Payout Ratio range over the past 10 years
Min: 0.1, Med: 0.15, Max: 0.18
Current: 0.1
0.1
0.18
3-Year Dividend Growth Rate (Per Share) 8.00
3-Year Dividend Growth Rate ranked higher than
50.59% of 85 companies
in the Medical Care industry.
Industry Max: 96.1, Med: 8.7, Min: -100
CHE: 8
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
3-Year Dividend Growth Rate range over the past 10 years
Min: -42.4, Med: 2.2, Max: 35.7
Current: 8
-42.4
35.7
Forward Dividend Yield % 0.35
Forward Dividend Yield ranked lower than
93.23% of 251 companies
in the Medical Care industry.
Industry Max: 9.57, Med: 1.99, Min: 0.12
CHE: 0.35
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield-on-Cost (5-Year) % 0.53
Yield-on-Cost (5y) ranked lower than
87.69% of 325 companies
in the Medical Care industry.
Industry Max: 1324.37, Med: 2.24, Min: 0.03
CHE: 0.53
Ranked among companies with meaningful Yield-on-Cost (5y) only.
Yield-on-Cost (5y) range over the past 10 years
Min: 0.5, Med: 1.1, Max: 1.83
Current: 0.53
0.5
1.83

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 595.55
Price-to-Tangible-Book ranked lower than
99.50% of 200 companies
in the Medical Care industry.
Industry Max: 1347.5, Med: 3.33, Min: 0.05
CHE: 595.55
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 2.22, Med: 5.82, Max: 600.03
Current: 595.55
2.22
600.03
Price-to-Projected-FCF 3.10
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
71.29% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
CHE: 3.1
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.59, Med: 1.27, Max: 3.44
Current: 3.1
0.59
3.44
Price-to-DCF (Earnings Based) 1.68
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked lower than
78.79% of 33 companies
in the Medical Care industry.
Industry Max: 6.43, Med: 1.81, Min: 0.5
CHE: 1.68
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.52, Med: 1.26, Max: 3.17
Current: 1.68
0.52
3.17
Price-to-Median-PS-Value 2.80
Price-to-Median-PS-Value ranked lower than
92.79% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
CHE: 2.8
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.28, Med: 0.84, Max: 2.82
Current: 2.8
0.28
2.82
Price-to-Peter-Lynch-Fair-Value 4.25
Price-to-Peter-Lynch-Fair-Value ranked lower than
100.00% of 55 companies
in the Medical Care industry.
Industry Max: 23.11, Med: 2.08, Min: 0.48
CHE: 4.25
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.5, Med: 1.4, Max: 9.07
Current: 4.25
0.5
9.07
Price-to-Graham-Number 27.33
Price-to-Graham-Number ranked lower than
99.20% of 125 companies
in the Medical Care industry.
Industry Max: 49.08, Med: 2.41, Min: 0.42
CHE: 27.33
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 1.26, Med: 2.38, Max: 29.03
Current: 27.33
1.26
29.03
Earnings Yield (Joel Greenblatt) % 4.26
Earnings Yield (Greenblatt) ranked lower than
62.64% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
CHE: 4.26
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2.3, Med: 9, Max: 14
Current: 4.26
2.3
14
Forward Rate of Return (Yacktman) % 8.83
Forward Rate of Return ranked lower than
63.91% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
CHE: 8.83
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 3.6, Med: 15.85, Max: 28.6
Current: 8.83
3.6
28.6

More Statistics

Revenue (TTM) (Mil) $ 1,805.51
EPS (TTM) $ 12.29
Beta 0.86
Volatility % 18.55
52-Week Range $ 260.03 - 354.43
Shares Outstanding (Mil) 15.94

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y